Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	1.49B -13.7%
Revenue (ttm)	724.35M +3.6%
Net Income	134.23M -10.4%
EPS	7.26 -10.4%
Shares Out	18.42M
PE Ratio	11.16
Forward PE	n/a
Dividend	7.00 (8.62%)
Ex-Dividend Date	Jun 13, 2025

Volume	2,342
Average Volume	24,543
Open	81.10
Previous Close	81.00
Day's Range	79.90 - 81.20
52-Week Range	76.60 - 117.50
Beta	0.04
RSI	39.94
Earnings Date	Mar 26, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2024, Winston Medical Supply's revenue was 695.08 million, a decrease of -1.97% compared to the previous year's 709.07 million. Earnings were 131.59 million, a decrease of -17.11%.